NSIM
INO icon

North Star Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

North Star Investment Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Hold
7
– – ﹤0.01% 1732
2026
Q1 		$12 Hold
7
– – ﹤0.01% 1697
2025
Q4 		$12 Hold
7
– – ﹤0.01% 1568
2025
Q3 		$16 Hold
7
– – ﹤0.01% 1314
2025
Q2 		$14 Hold
7
– – ﹤0.01% 1209
2025
Q1 		$11 Hold
7
– – ﹤0.01% 1197
2024
Q4 		$13 Hold
7
– – ﹤0.01% 1215
2024
Q3 		$40 Hold
7
– – ﹤0.01% 1176
2024
Q2 		$57 Hold
7
– – ﹤0.01% 1153
2024
Q1 		$97 Sell
7
-1
-13% -$9 ﹤0.01% 1217
2023
Q4 		$48 Hold
8
– – ﹤0.01% 1176
2023
Q3 		$37 Hold
8
– – ﹤0.01% 1265
2023
Q2 		$42 Hold
8
– – ﹤0.01% 1280
2023
Q1 		$77 Hold
8
– – ﹤0.01% 1286
2022
Q4 		$147 Hold
8
– – ﹤0.01% 1287
2022
Q3 		$0 Hold
8
– – ﹤0.01% 1154
2022
Q2 		$0 Hold
8
– – ﹤0.01% 1154
2022
Q1 		$0 Hold
8
– – ﹤0.01% 1172
2021
Q4 		$0 Hold
8
– – ﹤0.01% 1198
2021
Q3 		$1K Hold
8
– – ﹤0.01% 1079
2021
Q2 		$1K Hold
8
– – ﹤0.01% 1056
2021
Q1 		$1K Hold
8
– – ﹤0.01% 1019
2020
Q4 		$1K Buy
+8
New +$1.06K ﹤0.01% 995

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

North Star Investment Management's INO Position: Q2 2026 in Review

North Star Investment Management held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 7 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #1732.

North Star Investment Management first reported a position in INO in Q4 2020 and has held it in 23 quarters since. The position peaked at $1K in Q3 2021. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • North Star Investment Management held 7 shares of Inovio Pharmaceuticals worth $8 as of Q2 2026.
  • North Star Investment Management left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1732 holding.
  • North Star Investment Management first reported a position in Inovio Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • North Star Investment Management's Inovio Pharmaceuticals position peaked at $1K in Q3 2021.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.